Yep, your BS detector is proving to be well calibrated. I'm happy that at least you've been able to take advantage of your intuition with your trades! Still, it's disappointing when one loses trust in guidance from those who are supposed to be in the know
We're now looking at:
~36% miss on their own Q1 revenue guidance (no excuses for that)
>35% miss on Q1 EPS consensus (unfortunately, not unusual)
Re: calculator shortage - I want to be proven wrong but "delusional" springs to mind. If, and I really mean IF, they can achieve the $78.5M low end of guidance; I'd imagine revenue would need to look something like this:
Mar-24 Jun-24 Sep-24 Dec-24 FY24 1 Revenue (USD) $11.1M $18M $22M $27.4M $78.5M 2 Growth (mrq) -21% 62% 22% 25% 3 Growth (pcp) 6% 54% 62% 94% 58%
The above would imply that there will be bulk orders and pent-up demand for RECELL GO in June from the VAC approved hospitals in Q2, followed by strong adoption by surgeons in Q3/4. A successful launch and surgeon adoption of PermeaDerm would also help at this stage.
- Forums
- ASX - By Stock
- AVH
- Don't consider selling before profitability
Don't consider selling before profitability, page-273
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
|
|||||
Last
$2.37 |
Change
-0.010(0.42%) |
Mkt cap ! $157.1M |
Open | High | Low | Value | Volume |
$2.37 | $2.38 | $2.34 | $483.6K | 204.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $2.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.37 | 9842 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 2.360 |
2 | 2276 | 2.350 |
13 | 19718 | 2.340 |
5 | 46581 | 2.330 |
8 | 14803 | 2.320 |
Price($) | Vol. | No. |
---|---|---|
2.370 | 9842 | 2 |
2.400 | 1221 | 2 |
2.420 | 4132 | 1 |
2.430 | 4300 | 1 |
2.450 | 7500 | 1 |
Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |